Dawn Svoronos, Director of Xenon Pharmaceuticals XENE, has filed 1 purchase and 1 sale on the open market. The latest trade was on 06/03.

DS

DS

Dawn Svoronos

Director

Company

Xenon Pharmaceuticals XENE

First filing

23/05/04

Trades

31 trades

Buys / sales

1 / 1

12-month net buying

No record

Last trade

06/03

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Xenon PharmaceuticalsXENE	Open-market sale	23/08/24	23/08/24	25,000 sh	$38.70	$967,500	−50.0%
AC Acelyrin	Open-market buy	23/05/09	23/05/11	15,000 sh	$18.00	$270,000	No record